Onconova医疗

ONTX NASDAQ
2.410
+0.110
+4.78%
已收盘, 16:00 07/22 EDT
开盘
2.340
昨收
2.300
最高
2.710
最低
2.340
成交量
1.31万
成交均量(3M)
3.46万
52周最高
11.17
52周最低
1.690
换手率
0.22%
市值
1,445.64万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Onconova医疗 ONTX股票价格,Onconova医疗股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
展开 >

最近浏览

名称
价格
涨跌幅